Definite Lived Long-Lived Assets

6 Months Ended

Dec. 31, 2016

Intangible Assets Disclosure [Abstract]

Definite Lived Long-Lived Assets

DEFINITE LIVED LONG-LIVED ASSETS

The Company’s definite-lived long-lived assets include property, plant and equipment as well as other intangible assets with definite lives. Refer to Note 14 Supplemental Balance Sheet Information for details related to property, plant and equipment.

The details of other intangible assets subject to amortization as of December 31, 2016 and June 30, 2016, are as follows:

(Dollars in millions)	Weighted Average Life	Gross Carrying Value		Accumulated Amortization			Net Carrying Value
December 31, 2016
Amortized intangibles:
Core technology	18 years	$	165.2	$	(67.3	)	$	97.9
Customer relationships	14 years	242.6		(95.0		)	147.6
Product relationships	12 years	200.4		(162.0		)	38.4
Total intangible assets		$	608.2	$	(324.3	)	$	283.9

The increase in customer relationships is associated with the acquisition of Pharmatek Laboratories, Inc. in September 2016 and the preliminary fair value allocation.

(Dollars in millions)	Weighted Average Life	Gross Carrying Value		Accumulated Amortization			Net Carrying Value
June 30, 2016
Amortized intangibles:
Core technology	18 years	$	170.6	$	(64.9	)	$	105.7
Customer relationships	14 years	230.3		(90.9		)	139.4
Product relationships	12 years	208.6		(159.7		)	48.9
Total intangible assets		$	609.5	$	(315.5	)	$	294.0

Amortization expense was $11.1 million and $22.1 million for the three and six months ended December 31, 2016, respectively, and $11.7 million and $23.6 million for the three and six months ended December 31, 2015, respectively. Future amortization expense for the next five years is estimated to be:

(Dollars in millions)	Remainder   Fiscal 2017		2018		2019		2020		2021		2022
Amortization expense	$	22.1	$	44.1	$	38.6	$	25.1	$	25.1	$	25.1